tirzepatide uptodate (LY3298176) is a Dual GIP and GLP-1 Receptor Agonist for Type 2 Diabetes Research How to wean off tirzepatide:

Overall, triggering the activation of BAT or inducing the browning of WAT offers a highly effective approach to obesity treatment [16,19]

While mild appetite fluctuations during tirzepatide therapy may not require immediate intervention, certain situations warrant prompt communication with your healthcare provider to ensure treatment safety and efficacy

Always verify U-100 markings on the syringe barrel and packaging before use

Tirzepatide works best with a reduced-calorie diet and regular activity, but how you reach that calorie target depends on your: Tastes Culture Health needs Ask: Do you prefer three solid meals or smaller meals and snacks

The peptide appears to shift the body's fuel preference toward stored fat, which explains some of its weight management effects